September 22, 2000
For Sale: the Book of Life
Scholars and entrepreneurs enter brave new world of the human genome
In late June, newspapers heralded the end of a race between giants. Celera Genomics, a two-year-old company with a thick wallet, had sprinted to a tie with a publicly financed consortium of institutions that had been laboring since 1990 to spell out the sequence of chemical letters in
This content is only for subscribers. You can gain access by purchasing a:
Print Subscription
Digital Subscription
Already have an account? Log In Now.
-
The Chronicle Review
-
Government
-
Advice
